Morristown Medical Center

Futó vizsgálatok

• Toboroz

  Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

  NCT07215910· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Toboroz

  A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

  NCT07419295· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

  NCT07068074· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás

• Toboroz

  Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

  NCT07057791· 2. fázis· PrECOG, LLC.· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  NCT07284849· 3. fázis· Incyte Corporation· Forrás

• Toboroz

  EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

  NCT07262619· 1/2. fázis· Eikon Therapeutics· Forrás

• Toboroz

  Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  NCT07166094· 3. fázis· Genmab· Forrás

• Toboroz

  A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  NCT06405087· 3. fázis· Takeda· Forrás

• Toboroz

  Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

  NCT07069738· Boston Scientific Corporation· Forrás

• Toboroz

  Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  NCT06317662· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  NCT06124157· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

  NCT06881784· 3. fázis· Revolution Medicines, Inc.· Forrás

• Toboroz

  A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

  NCT06401330· 3. fázis· Children's Oncology Group· Forrás

• Fut, nem toboroz

  TECTONIC CAD IVL IDE Study

  NCT06885177· Abbott Medical Devices· Forrás

• Toboroz

  A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

  NCT06644781· 3. fázis· Daiichi Sankyo· Forrás

• Toboroz

  Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

  NCT06661720· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Toboroz

  AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

  NCT06793371· 2. fázis· Cytokinetics· Forrás

• Toboroz

  Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  NCT06418204· Wake Forest University Health Sciences· Forrás

• Toboroz

  DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  NCT06388421· United Therapeutics· Forrás

• Toboroz

  A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  NCT06667076· 2. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

  NCT06504589· Nicole Hamblett· Forrás

• Fut, nem toboroz

  Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

  NCT06538038· PrECOG, LLC.· Forrás

• Fut, nem toboroz

  A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)

  NCT06455098· Biosense Webster, Inc.· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).

  NCT06412666· 2/3. fázis· Cytokinetics· Forrás

• Toboroz

  Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  NCT06172296· 3. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

  NCT06295367· ECOG-ACRIN Cancer Research Group· Forrás

• Meghívásos bevonás

  ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

  NCT05932615· Abbott Medical Devices· Forrás

• Fut, nem toboroz

  Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

  NCT06117774· 3. fázis· Amgen· Forrás

• Fut, nem toboroz

  A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

  NCT06111235· 3. fázis· CG Oncology, Inc.· Forrás

• Fut, nem toboroz

  Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure

  NCT05598333· 2. fázis· AskBio Inc· Forrás

• Toboroz

  Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  NCT05879926· 3. fázis· NRG Oncology· Forrás

• Fut, nem toboroz

  Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

  NCT06002828· ECOG-ACRIN Cancer Research Group· Forrás

• Toboroz

  Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

  NCT05929768· 3. fázis· SWOG Cancer Research Network· Forrás

• Fut, nem toboroz

  A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

  NCT06081894· 3. fázis· Cytokinetics· Forrás

• Fut, nem toboroz

  Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

  NCT05893498· CathWorks Ltd.· Forrás

• Toboroz

  Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

  NCT05812807· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Toboroz

  A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

  NCT05675410· 3. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

  NCT05548283· 4. fázis· Chris Goss· Forrás

• Fut, nem toboroz

  A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

  NCT05578976· 3. fázis· Genmab· Forrás

• Fut, nem toboroz

  Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation and Continuing Response

  NCT05610163· 2/3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Fut, nem toboroz

  A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

  NCT05444257· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás

• Fut, nem toboroz

  A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension

  NCT05203510· 4. fázis· United Therapeutics· Forrás

• Fut, nem toboroz

  Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

  NCT05183035· 3. fázis· PedAL BCU, LLC· Forrás

• Fut, nem toboroz

  Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

  NCT05409066· 3. fázis· Genmab· Forrás

• Toboroz

  Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  NCT05334069· Alliance for Clinical Trials in Oncology· Forrás

• Fut, nem toboroz

  A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma

  NCT05451810· 2. fázis· Genmab· Forrás

• Toboroz

  Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

  NCT05304585· 3. fázis· Children's Oncology Group· Forrás

• Fut, nem toboroz

  Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients

  NCT05222555· 1/2. fázis· Incyte Corporation· Forrás

• Toboroz

  Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

  NCT05174169· 2/3. fázis· NRG Oncology· Forrás

• Fut, nem toboroz

  Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study

  NCT05092958· 3. fázis· National Cancer Institute (NCI)· Forrás

Showing 50 of 161.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok20 toboroz
• Akut limfoid leukémia (ALL)6 toboroz
• Vastagbélrák6 toboroz
• Petefészekrák4 toboroz
• Tüdőrák4 toboroz
• Akut mieloid leukémia (AML)3 toboroz
• Gyomor- és nyelőcsőrák3 toboroz
• Melanóma3 toboroz
• Vesedaganat3 toboroz
• Áttétes emlőrák2 toboroz
• Cisztás fibrózis2 toboroz
• Down syndrome2 toboroz
• Hasnyálmirigyrák2 toboroz
• Hólyagrák2 toboroz
• Méhtestrák2 toboroz
• Mielóma multiplex2 toboroz
• Neuroblasztóma2 toboroz
• Prosztatarák2 toboroz
• Szarkóma2 toboroz
• Szívelégtelenség2 toboroz
• Tripla negatív emlőrák2 toboroz
• Aortic stenosis1 toboroz
• Colitis ulcerosa1 toboroz
• Crohn-betegség1 toboroz
• Fej-nyaki daganatok1 toboroz
• Hipertrófiás kardiomiopátia1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Krónikus mieloid leukémia (CML)1 toboroz
• Magas vérnyomás1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Neuroendokrin daganatok1 toboroz
• Pulmonális artériás hipertónia1 toboroz

Lezárt vizsgálatok

• Lezárult

  The ShortCut™ Continued Access Study Protocol

  NCT06211296· Pi-cardia· Forrás

• Lezárult

  The PROTEMBO Trial

  NCT05873816· Protembis GmbH· Forrás

• Lezárult

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM

  NCT05767346· 3. fázis· Cytokinetics· Forrás

• Leállították

  Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC

  NCT05814666· 2. fázis· Flamingo Therapeutics NV· Forrás

• Leállították

  A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer

  NCT05678257· 2. fázis· NuCana plc· Forrás

• Lezárult

  A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

  NCT05360680· 1. fázis· Cue Biopharma· Forrás

• Lezárult

  Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System

  NCT05293639· Biosense Webster, Inc.· Forrás

• Leállították

  A Study of Bemarituzumab Monotherapy and Combination With Other Anti-cancer Therapy in SqNSCLC With FGFR2b Overexpression (FORTITUDE-201)

  NCT05267470· 1. fázis· Amgen· Forrás

• Lezárult

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM

  NCT05186818· 3. fázis· Cytokinetics· Forrás

• Lezárult

  Safe Surveillance of PCI Under Mechanical Circulatory Support With the Saranas Early Bird Bleed Monitoring System

  NCT05077657· Saranas, Inc.· Forrás

• Lezárult

  A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation

  NCT05076149· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás

• Lezárult

  A Study of SEA-CD40 Given With Other Drugs in Cancers

  NCT04993677· 2. fázis· Seagen Inc.· Forrás

• Lezárult

  realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

  NCT04981795· Incyte Corporation· Forrás

• Lezárult

  A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)

  NCT05033080· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás

• Lezárult

  A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

  NCT04673357· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)

  NCT04630028· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma

  NCT04396860· 2/3. fázis· National Cancer Institute (NCI)· Forrás

• Leállították

  A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors

  NCT04157517· 1/2. fázis· Teva Branded Pharmaceutical Products R&D LLC· Forrás

• Lezárult

  Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia

  NCT03836209· 2. fázis· PrECOG, LLC.· Forrás

• Lezárult

  Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula

  NCT04075825· 3. fázis· Takeda· Forrás

• Lezárult

  Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment

  NCT04116437· 2. fázis· BeiGene· Forrás

• Lezárult

  Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer

  NCT03362177· 3. fázis· Amgen· Forrás

• Lezárult

  Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy

  NCT03860961· NRG Oncology· Forrás

• Lezárult

  Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

  NCT03924856· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Leállították

  Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

  NCT03645928· 2. fázis· Iovance Biotherapeutics, Inc.· Forrás

• Leállították

  A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas

  NCT03893682· 1. fázis· Aptose Biosciences Inc.· Forrás

• Leállították

  Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

  NCT03646123· 2. fázis· Seagen Inc.· Forrás

• Lezárult

  A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia

  NCT03734016· 3. fázis· BeiGene· Forrás

• Lezárult

  Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

  NCT03526250· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Early Feasibility Study - Edwards APTURE Transcatheter Shunt System

  NCT03523416· Edwards Lifesciences· Forrás

• Lezárult

  Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer

  NCT03382561· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

  NCT03092674· 2/3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

  NCT03213678· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

  NCT03213665· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

  NCT03220035· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

  NCT03213691· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR

  NCT07227675· Abbott Medical Devices· Forrás

• Lezárult

  Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

  NCT03233204· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement

  NCT02828358· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia

  NCT02723994· 2. fázis· Incyte Corporation· Forrás

• Lezárult

  A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer

  NCT02716116· 1/2. fázis· Takeda· Forrás

• Lezárult

  Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

  NCT02180867· 2/3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma

  NCT01979536· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas

  NCT01793233· Children's Oncology Group· Forrás

• Lezárult

  Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

  NCT01798004· 1. fázis· Children's Oncology Group· Forrás

• Toboroz

  Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

  NCT02688517· Rutgers, The State University of New Jersey· Forrás

• Lezárult

  Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement

  NCT01675440· Medtronic Cardiovascular· Forrás

• Lezárult

  Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

  NCT01553149· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors

  NCT01602666· 2. fázis· Children's Oncology Group· Forrás

• Lezárult

  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations

  NCT02883049· 3. fázis· National Cancer Institute (NCI)· Forrás

Showing 50 of 78.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Aortic stenosis22 munka · 6 vizsgálat
• Hipertrófiás kardiomiopátia12 munka · 5 vizsgálat
• Lyme disease3 munka · 0 vizsgálat